Niskinase 7.5IU Injection
Marketer
Neiss Labs Pvt Ltd
Salt Composition
Streptokinase (7.5IU/ml)
Overview Niskinase 7.5IU Injection
Urokinase 7.5IU Injection dissolves dangerous blood clots obstructing blood vessels. It's indicated for patients recovering from myocardial infarction and is also employed in the management of pulmonary embolism and stroke. Administration requires strict medical oversight; dosage and treatment length are determined individually by your physician, who will monitor your progress until stabilization. Potential side effects include injection site hemorrhage, nausea, hypersensitivity reactions, and hypotension. Increased bleeding risk is also a possibility. Your doctor will discuss the therapy's benefits and risks prior to administration. Continue all prescribed medications for your underlying condition, even after this injection. Caution is warranted for patients with bleeding disorders, hepatic or renal impairment. Disclose any existing medical conditions, including pregnancy or breastfeeding, and a complete list of your medications to your physician.
Primary Ingredients of Niskinase 7.5IU Injection
The provided text is "undefined," which cannot be rephrased while maintaining meaning and length. A rephrased version would require actual text to work with.
Uses of Niskinase 7.5IU Injection
Myocardial infarction/Pulmonary thromboembolism
Major Benefits of Niskinase 7.5IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
Common Side effects of Niskinase 7.5IU Injection:
- Allergic reaction
- Nausea
- Injection site bleeding
- Decrease in blood pressure
How to use Niskinase 7.5IU Injection:
This medication will be administered by your healthcare provider. Self-medication is strongly discouraged.
How Niskinase 7.5IU Injection works:
Thrombolytic therapy with Niskinase 7.5IU Injection breaks down dangerous blood clots within the vasculature. This action re-establishes blood circulation to compromised tissues, averting necrosis and leading to better patient results.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
The safety of combining alcohol with Niskinase 7.5IU Injection is undetermined. Seek medical advice before concurrent use.
PregnancyCONSULT YOUR DOCTOR
The use of Niskinase 7.5IU Injection during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the compatibility of Niskinase 7.5IU Injection with breastfeeding are currently unavailable. Seek medical advice from your physician.
DrivingNOT RELEVANT
Inapplicable, given that Niskinase 7.5IU Injection is administered solely to inpatients.
KidneySAFE IF PRESCRIBED
The use of Niskinase 7.5 IU Injection in individuals with kidney disease appears to present a low risk. Current evidence indicates dose modification may be unnecessary; however, this is based on limited data. Physician consultation is advised. Niskinase 7.5 IU Injection is contraindicated in patients exhibiting severe kidney impairment.
LiverCAUTION
For patients with significant hepatic impairment, Niskinase 7.5IU Injection requires careful administration and may necessitate dose modification. Physician consultation is recommended.
What if you forget to take Niskinase 7.5IU Injection :
Should you forget a Niskinase 7.5IU Injection, seek your physician's advice.
Facts to Know About Niskinase 7.5IU Injection
| Label | Value |
|---|---|
| Chemical Type | Amino acid and peptide analogs |
| Developing Habits | No. |
| Type of Therapy | Heart |
| Actions | Early Thrombolytic Agents |
3,018 People bought this recently